Listen To The Lancet Haematology podcast

#Science #Podcasting Education #Health and Well-Being #Lancet #Lancet Haematology #Medicine #Research

43:08

"But it makes a lot of sense especially when you think about how traditional healers and shamans have worked, they haven't felt that separation from nature like Western medics do. And so to rely on the knowledge of other species actually makes a lot of sense. It's probably a lot more than we know at the moment." - Jaap de Roode Jaap de Roode is a biology professor at Emory University, and he is the author of an astonishing new book called Doctors by Nature How Ants, Apes, and Other Animals Heal Themselves . I say astonishing because I had no idea about so much of what he explores in his book. It never occured to me to consider that other species use medicine and have been healing themselves forever. Jaap tells stories of animals across nature, from bumblebees to chimpanzees, how they use plants and natural substances to treat infections, to ward off parasites, to self-medicate. There's so much that we have learned from them, and there's so much more that we still can.…

Listen to The Lancet Haematology

Distribuie

Pagina seriei•Feed

The Lancet Haematology launched in Autumn 2014, joining the growing collection of Lancet specialty journals. As an exclusively online journal, this new monthly title is dedicated to publishing original research that advocates change in, or illuminates, haematological clinical practice.

54 episoade

Listen to The Lancet Haematology

updated acum 6 ore

Distribuie

Pagina seriei•Feed

54 episoade

#Science #Podcasting Education #Health and Well-Being #Lancet #Lancet Haematology #Medicine #Research

Toate episoadele

1
In conversation with... Joanne Verweij and Romy Pothof 17:47

acum 6 hours17:47

17:47

Dr Romy Pothof and Prof Joanne Verweij join us to discuss their development of an international consensus on the diagnosis and treatment of fetal and neonatal alloimmune thrombocytopenia.

1
In conversation with... Helene Schoemans, Elke Stienissen, and Kathy Goris 27:06

acum 29 zile27:06

27:06

Prof Helene Schoemans, Elke Stienissen, and Kathy Goris join us to discuss the importance of consulting a patient advisory board to understand unmet needs of patients with GVHD in Europe.

1
In conversation with... Dawn Swan 15:02

acum 9 weeks15:02

15:02

Dr Dawn Swan joins us to discuss current knowledge and future perspectives on the possible association between air pollution and venous thromboembolism.

1
In conversation with... Leslie Skeith 16:03

acum 11 weeks16:03

16:03

Dr Leslie Skeith joins us to discuss the PARTUM pilot trial, comparing low-dose aspirin versus placebo in postpartum venous thromboembolism.

1
In conversation with... Neema Mayor and Caitlin Farrow 17:55

acum 17 weeks17:55

17:55

Dr Neema Mayor and Dr Caitlin Farrow from the Anthony Nolan Research Institute join us to discuss the findings of their study on the impact of patient ethnicity on haematopoietic cell transplantation outcomes in the United Kingdom.

1
Lancet Haematology 10 year anniversary - meet the editors 47:21

acum 26 weeks47:21

47:21

In a special 10 year anniversary podcast, Lan-Lan Smith, Yaiza del Pozo Martin, and Emma Cookson, the editorial team behind The Lancet Haematology , reflect on the last decade and give some insights into the editorial processes at The Lancet Group.

1
In conversation with... Matteo Giovanni Della Porta 8:08

acum 32 weeks8:08

8:08

Professor Matteo Giovanni Della Porta joins us to discuss the primary analysis of the phase 3 COMMANDS trial comparing luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndrome patients.

1
In conversation with... Kim Linton 9:48

acum 34 weeks9:48

9:48

Dr Kim Linton joins us to discuss the EPCORE NHL-1 trial testing monotherapy with the bispecific antibody epcoritamab for patients with relapsed or refractory follicular lymphoma.

1
In conversation with... Judy Truong 11:17

acum 34 weeks11:17

11:17

Dr Judy Truong join us to discuss ferritin reference intervals and how adoption of evidence-based ferritin clinical decision limits can help clinicians detect and treat iron deficiency, minimising propagation of related health inequity and social injustice in medicine.

1
In conversation with... Johannes Schetelig 14:11

acum 37 weeks14:11

14:11

Professor Johannes Schetelig joins us to discuss the results of the ASAP phase 3 trial comparing remission induction with immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia.

1
In conversation with... Banu Aygun 11:13

acum 45 weeks11:13

11:13

Professor Banu Aygun joins us to discuss the REACH trial testing hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa.

1
In conversation with... Sabine Braat and Katherine Fielding 18:06

acum 1 year18:06

18:06

Dr Sabine Braat and Dr Katherine Fielding join us to discuss their study presenting new haemoglobin thresholds for defining anaemia.

1
In conversation with... Elisabeth Schorb 9:23

acum 1 year9:23

9:23

Doctor Elisabeth Schorb joins us to discuss the MARTA phase 2 trial, treating older, fit patients with primary diffuse large B-cell CNS lymphoma with high-dose chemotherapy and autologous stem-cell transplantation.

1
In conversation with... Stephan Ehl 13:03

acum 1 year13:03

13:03

Professor Stephan Ehl joins us to discuss a prospective observational study on paediatric autoimmune lymphoproliferative immunodeficiencies.

1
In conversation with... Sarah O'Brien 13:50

acum 1 year13:50